Stay updated on Tavo in Melanoma Post-Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Tavo in Melanoma Post-Checkpoint Inhibitors Clinical Trial page.

Latest updates to the Tavo in Melanoma Post-Checkpoint Inhibitors Clinical Trial page
- Check2 days agoChange DetectedThe page now shows a new revision tag (v3.5.4) replacing the previous revision (v3.5.3). This signals a page build update rather than changes to the study content.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page’s technical release indicator updates from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a site software/version change rather than any change to the clinical trial record.SummaryDifference0.0%

- Check30 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check51 days agoChange DetectedThe location entry for Italy was updated from Napoli, Italy, 80131 to Naples, Italy, 80131.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a system-wide update and does not affect study details.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

Stay in the know with updates to Tavo in Melanoma Post-Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tavo in Melanoma Post-Checkpoint Inhibitors Clinical Trial page.